Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brilliant ...thanks
Congrats and welcome.... .20 - .30 in August...conservatively IMO
That’s great DD SCHH....love Hilton Head... can’t wait for the future numbers... Next week is just the beginning
N2k on one a day...medium size Pharma’s are allowed up to 19 ANDA’s....Elite is below that threshold... Anything over 19 would warrant the 2 million additional fee that Nasrat has mentioned.
Not true..... I absolutely like the current way Nasrat and team conduct the CC... they are very informational and much easier to understand and follow along. Nasrat does a great job of answering as many questions not redundant as possible.
As always thanks for your very insightful post. I too believe a big merger is imminent..
Big merger coming... beware
Great post Jour... fair and balanced
Nope, second shift just added... glad to help
Elite adding a second shift to deal with all those headaches... too funny
Great DD bluejay.. thank you
ELTP.... busy weekend...I wonder why?
How about you copy and paste it here for all to read them?.... asking for a friend..
And just how would you know this?...hmmmm!!!!..yeah I want more shares too.
Excitement is building with Elite with all this chatter... Record revenues coming.. Elite is way undervalued.. stayed tuned in the next few weeks...
Thanks for the facts and if you look back a year you can see dilution has been minimal.
I will take a merger, reverse merger or anything to get us off this cesspool exchange. Gladly take our chances elsewhere...
Good catch... I never noticed...too funny... maybe we can do it a third time.
Got the email for one of my accounts... voted FOR of course...the wife and I are waiting for the email for our other accounts..
This is great... Lannett down 20% today....Elite gets blamed...lol...can’t make it up...
You might want to freshen up on your DD
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=2ahUKEwjW8O7x94HpAhUIac0KHSL9ApsQFjABegQIChAF&url=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fthese-are-the-public-companies-that-got-small-business-loans-11587493742&usg=AOvVaw03J160ytpL8H8NseuPDZo6
Haha.. just more BS... the banks ran out of money from the first Bill.... Congress had to write anyone... so obviously the banks were writing the loans...
Wow.... you should tell that to the millions of small businesses that are hurting and applied for the PPP and many have already received it. How can this be bad for them. Now I know that with the lack of oversight that some businesses will receive the PPP that really don’t need it. Maybe Elite falls in this category..they will be cash flow positive next quarter.
But I would think less of Nasrat if he didn’t apply for the PPP...it’s a Grant....non repayable....even if you don’t use the money for payroll and/ or utilities... then it’s considered a loan to be paid back at 1%.... that’s a heck of a lot cheaper than LPC financing...
This just make smart business sense...let me know what bank you can get cheaper than 1%....working for a top 5 company... I would expect more.
My point is ....that this money if used for payroll... let’s say to support a second shift now that Elite is ramping up. Will be considered as a grant and not have to be repaid. If not used for payroll,rent and utilities. It’s considered a loan and paired back at a great rate of 1%... Either way.. this is huge for our business in this critical time.
Elite will benefit from the “payroll protection plan”.. which 75% will go for payroll and 25% for rent and utilities.
As an essential business that has remained open. Elite will benefit from this and most certainly help with the bottom line.
Thanks AR for the clarification.... although we won’t get lost months back....
Yeah and maybe that is one of the reasons... I honestly have no clue and am beyond frustrated...
I can’t for the life of me understand what went wrong with the vote... The auditors were present at the meeting in December..This has to fall on the responsibilities of the auditors somehow. I’m not familiar with their duties.
As a matter of fact.... a couple of shareholders that were present had not voted yet and asked if they still could. It was determined that they could still do so although it was said that it really wouldn’t matter on the final results. Meaning it was overwhelmingly passed.
I also believe that the going concern could also be removed based on Elite providing evidence of CFP on the year end financials. Makes sense why the pipeline hasn’t been progressing now.
Hopefully the cost of this undertaking will be recovered.
I agree, organic growth is needed to maximize ours and Nasrats investments first...
We have come a long way. We have stopped and pivoted our business model.
We have worked through FDA game playing ..
We have successfully partnered with SunGen, GlenMark, and Lannett...
We have developed, filed and launched a new pipeline of drugs.
We have recorded record breaking quarterly financials
Patience regarding the PPS have been stretched to the limit. But IMO, by the end of this calendar year. All investors will be rewarded.
Eight more months... We’ve got this...
Still waiting for that list of the best companies that will fly... We’ll invest with you...and TIA for posting them on crappy penny stock board instead of on the big boy boards.
It is because only users that pay for this site can see them... the rest, which is the majority can not...
Nice read... thanks for sharing.. confirms Elite not having any problem with their launch of Adderall XR..
Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
Shares of generic drug makers have been pounded in recent years, pressured by lawsuits over the opioid crisis, falling prices for medicines, and other worries. But in a note Tuesday morning, SVB Leerink analyst Ami Fadia argued that the Covid-19 pandemic could, paradoxically, bring some relief to the sector in the long term.
Fadia argued that generic-drug pricing could rise in the short term due to scarcity created by supply-chain disruptions, and that in the long term, consumers might be willing to pay higher prices for a more secure supply. To that end, she argued, the Covid-19 crisis could result in generic drug makers bringing manufacturing back to the U.S. from India and China, where it is heavily concentrated.
“The concern about the dependency of the US supply chain on nations such as China has been known about for some time, but COVID-19 has illuminated the risks of this dependency at a whole new level,” Fadia wrote. “The reverberating impacts of COVID-19 may compel the government to assist pharma companies to take the steps necessary to bring manufacturing of essential drugs back to the US for the prospect of greater control and assurance of the supply chain.”
Shares of Teva Pharmaceutical Industries (ticker: TEVA) are down 3.5% so far this year, while the S&P 500 is down 17%. Shares of other generic drug makers have performed worse in 2020, including Amneal Pharmaceuticals (AMRX), which is down 34.9%; Endo International (ENDP), which has fallen 31.6%; and Mallinckrodt (MNK), off 48.8%.
n her note, Fadia wrote that prices for generic drugs will rise in the near term as companies seek to maintain their supply chains amid challenging circumstances. Those price bumps won’t necessarily last. But Fadia argued that, in the long term, companies with more robust risk mitigation built into their supply chains could be in a position to negotiate for higher prices.
As for a shift of manufacturing back to the U.S., Fadia wrote that crisis has highlighted the risks inherent in the industry’s choice to move manufacturing overseas. That has manifested in worries about drug shortages due to the concentration of active pharmaceutical ingredient manufacturing in China, and in limitations that Indian authorities have imposed on the export of certain drugs, including hydroxychloroquine.
Fadia wrote that drug making had been outsourced for environmental reasons and because of costs, and said there could be “meaningful hurdles precluding large-scale repatriation” of the manufacturing processes. But at the same time, she said, the effects of the crisis could, in the longer term, force the government to help the industry bring at least some manufacturing back to the U.S.
I had emailed Dianne months ago and asked this exact question and reply was NO... Elite only sells in the United States currently..hope that helps..maybe it’s changed..
Ok we can all starting waiting for all the posts concerning the current PPS numbers... lol... always something... although we might see a little bump in the PPS. I don’t expect a spike until the real revenue numbers start getting reported....
Hope everyone has been accumulating whenever possible. Your patience will be rewarded.
Congrats to Elite and partners... and a special appreciation to its employees during these difficult times...
What... you mean that Nasrat and their partners actually meet another expected timeline?... Holding true to what they have said...!!! No matter how many times it’s posted to the contrary ...
Moose, emailed Lannett’s IR dept. about when they expect to launch... Here was their response to him a few weeks ago...
Moose
10:47 AM (57 minutes ago)
When will Adderall XR launch?
Rita Augustine
11:22 AM (22 minutes ago)
to CustomerService, me
Good day,
The launch is expected end of March /April 2020.
Please see www.Lannett.com products tab for product information.
Regards,
Client Relations Associate | Lannett Company Inc. | p: 215-333-9000 ext. 4 | f: 267-350-0069
Thanks for all the DD Sharkey1.... can’t wait to see the impact from these drugs in the revenues reported..I think by our November Q.... numbers including sales and manufacturing fees should be outstanding... Great things finally happening for Elite..
and look at Elites chart, this share price has nothing to do with the economy !!!!!!!!!!!!!!!!!!
And how does one know this for sure..????????????????????????????????
Agreed.. I’m sure in this current financial climate Nasrat is managing what funds are left extremely responsibly.
It would be naive for shareholders to believe that with the breakout of this virus in the NY/NJ area that Elite and its partners Lannett and SunGen and others have not been affected directly or indirectly...
I just hope and pray existing supply chains stay in place and running.
Elite will live for another day... GLTA... flatten the curve...
HERE IS THE FACTS...an email from investor relations from Lannett..
Moose
10:47 AM (57 minutes ago)
When will Adderall XR launch?
Rita Augustine
11:22 AM (22 minutes ago)
to CustomerService, me
Good day,
The launch is expected end of March /April 2020.
Please see www.Lannett.com products tab for product information.
Regards,
Client Relations Associate | Lannett Company Inc. | p: 215-333-9000 ext. 4 | f: 267-350-0069